$224.58
0.98% today
NYSE, Nov 21, 08:15 pm CET
ISIN
US0758871091
Symbol
BDX

Becton, Dickinson & Stock price

$222.39
-18.13 7.54% 1M
-14.74 6.22% 6M
-21.44 8.79% YTD
-11.28 4.83% 1Y
-16.75 7.01% 3Y
-18.21 7.57% 5Y
+95.26 74.93% 10Y
NYSE, Closing price Wed, Nov 20 2024
-0.25 0.11%
ISIN
US0758871091
Symbol
BDX
Sector

Key metrics

Market capitalization $64.28b
Enterprise Value $82.09b
P/E (TTM) P/E ratio 37.43
EV/FCF (TTM) EV/FCF 26.71
EV/Sales (TTM) EV/Sales 4.07
P/S ratio (TTM) P/S ratio 3.19
P/B ratio (TTM) P/B ratio 2.48
Dividend yield 1.71%
Last dividend (FY24) $3.80
Revenue growth (TTM) Revenue growth 4.16%
Revenue (TTM) Revenue $20.18b
EBIT (operating result TTM) EBIT $2.88b
Free Cash Flow (TTM) Free Cash Flow $3.07b
Cash position $2.30b
EPS (TTM) EPS $5.94
P/E forward 23.79
P/S forward 2.92
EV/Sales forward 3.73
Short interest 0.71%
Show more

Is Becton, Dickinson & a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Becton, Dickinson & Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Becton, Dickinson & forecast:

16x Buy
89%
2x Hold
11%

Analyst Opinions

18 Analysts have issued a Becton, Dickinson & forecast:

Buy
89%
Hold
11%

Financial data from Becton, Dickinson &

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
20,178 20,178
4% 4%
100%
- Direct Costs 11,025 11,025
2% 2%
55%
10,853 10,853
33% 33%
54%
- Selling and Administrative Expenses 5,080 5,080
116% 116%
25%
- Research and Development Expense 1,190 1,190
4% 4%
6%
5,169 5,169
13% 13%
26%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 2,883 2,883
19% 19%
14%
Net Profit 1,726 1,726
16% 16%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Becton, Dickinson & directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Becton, Dickinson & Stock News

Neutral
PRNewsWire
one day ago
BROWNSVILLE, Texas , Nov. 20, 2024 /PRNewswire/ -- A first of its kind Human Papillomavirus (HPV) self-collection screening pilot program aimed at improving cervical cancer screening in underserved communities has officially launched in Texas. HPV is the cause of virtually all cervical cancers.
Neutral
PRNewsWire
2 days ago
FRANKLIN LAKES, N.J. , Nov. 19, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 7th Annual Evercore ISI HealthCONx Conference on Tuesday, December 3, 2024, at 10:50 am Eastern Time.
Positive
Seeking Alpha
9 days ago
Becton, Dickinson and Company is projected to achieve 8.8%-9.3% revenue growth in FY25, driven by new product launches and the APM business. The acquisition of Edwards Lifesciences' Critical Care product group is expected to significantly boost BD's Advanced Patient Monitoring segment. BD plans to reduce debt leverage to 2.5x and repurchase $1 billion in shares, enhancing financial stability an...
More Becton, Dickinson & News

Company Profile

Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.

Head office United States
CEO Thomas Polen
Founded 1897
Website www.bd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today